期刊文献+

HPLC-MS/MS法测定大鼠血浆中麻醉椒苦素的浓度及其药动学研究 被引量:2

Determination and pharmacokinetics of methysticin in rat plasma by HPLC-MS/MS
原文传递
导出
摘要 目的:建立大鼠血浆中卡瓦内酯麻醉椒苦素的液相色谱质谱联用定量分析方法,并用于大鼠体内药物动力学研究。方法:采用Waters Symmetry Shield C8(3.0 mm×150 mm,5.0μm)色谱柱,流动相为乙腈-0.2%甲酸溶液(60∶40,v/v)。三重四极杆质谱仪进行多反应监测(MRM)模式,电喷雾离子源(ESI)正离子检测。生物样品预处理采用乙酸乙酯液-液萃取,考察麻醉椒苦素灌胃给药后,大鼠体内药物动力学特征。结果:在大鼠血浆中麻醉椒苦素浓度与峰面积比呈良好线性关系(r=0.9998),线性范围为10~20000μg·L-1,定量下限为10μg·L-1,样品分析时间为5.5 min。日内、日间精密度(RSD)均小于5.3%,准确度在±10.3%之内。SD大鼠灌胃给药麻醉椒苦素120 mg·kg-1后,平均血药峰浓度为8.92 mg·L-1,血药浓度达峰时间平均为4.00 h。结论:所建立的HPLC-MS/MS定量分析方法特异、快速、灵敏,可用于麻醉椒苦素临床前药物动力学研究。 Objective :To establish a high performance liquid chromatography -tandem mass spectrometric method ( HPLC - MS/MS) for the determination of methysticin in rat plasma, which was used subsequently to determine the pharmacokinetics of methysticin in rats. Methods: A Waters Symmetry Shield C8 column ( 3.0 mm × 150 mm, 5.0 μm) was used with a mobile phase consisting of acetonitrile - 0. 2% formic acid ( 60: 40, v/v). The determination was performed with electrospray ionization (ESI)source in the positive multiple reaction monitoring(MRM) mode by a triple quadrupole tandem mass spectrometer. Rat plasma sampl.es were pretreated with ethyl acetate for liquid - liquid extraction of methysticin. Experiments were conducted to determine the pharmacokinetics of methysticin fol- lowing a single intragastric dose. Results:A good linearity of methysticin was obtained in the concentration range of 10 -20000 .g. L-1 (r =0. 9998). The limit of quantification(LOQ)was 10 .g . L-1. The run time for each sam- ple was 5.5 rain. The intra -and inter -day precisions at four quality control( QC)levels were all less than 5.3%. The accuracy of the assay was within ± 10. 3%. The average maximum concentration of drug( Cmax) was 8.92 mg.L- 1 and the time to the maximum concentration ( Tmax ) was 4.00 h after a single intragastric administration of me- thysticin to SD rats at a dose of 120 mg . kg-1. Conclusion:A sensitive,rapid and precise LC -MS/MS method is developed and validated for determination of methysticin in rat plasma. The method is proved to be suitable for the preclinical pharmacokinetics of methysticin.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第9期1480-1485,共6页 Chinese Journal of Pharmaceutical Analysis
基金 "重大新药创制"国家科技重大专项课题(编号2009ZX09103-414)
关键词 麻醉椒苦素 卡瓦胡椒内酯 药物动力学 高效液相色谱-串联质谱 电喷雾离子源 生物样品分析 methysticin kavalactones pharmacokinetics HPLC - MS/MS ESI biological sample analysis
  • 相关文献

参考文献15

  • 1Pepping J.Kava:Piper methysticum.Am J Health Syst Pharm,1999,56(10):957.
  • 2王厄舟,潘胜利,张淑芳.卡瓦胡椒化学成分及药理活性研究进展[J].中草药,2001,32(9):855-858. 被引量:10
  • 3Weiss J,Sauer A,Frank A,et al.Extracts and kavalactones of Piper methysticum G.Forst(kava-kava)inhibit P-glycoprotein in vitro.Drug Metab Dispos,2005,33(11):1580.
  • 4Fr?hlich M,Albermann S,Sauer A,et al.In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins.Biochem Pharmacol,2004,68(12):2409.
  • 5Li Y,Mei H,Wu Q,et al.Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.Toxicol Sci,2011,124(2):388.
  • 6Shaik AA,Hermanson DL,Xing CG.Identification of methysticin as a potent and non-toxic NF-кB inhibitor from kava,potentially responsible for kava's chemopreventive activity.Bioorg Med Chem Lett,2009,19(19):5732.
  • 7Kumar A,Takada Y,Boriek AM,et al.Nuclear factor-kappa B:its role in health and disease.J Mol Med,2004,82(7):434.
  • 8Mathews JM,Etheridge AS,Valentine JL,et al.Pharmacokinetics and disposition of the kavalactone kawain:interaction with kava extract and kavalactones in vivo and in vitro.Drug Metab Dispos,2005,33(10):1555.
  • 9Anke J,Ramzan I.Pharmacokinetic and pharmacodynamic drug interactions with Kava(Piper methysticum Forst.f.).J Ethnopharmacol,2004,93(2-3):153.
  • 10杨晓云,田金改,吴爱英,高天兵.HPLC法测定卡瓦胡椒内酯的含量[J].中国临床药学杂志,2003,12(3):173-175. 被引量:3

二级参考文献5

共引文献25

同被引文献57

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部